Current Status of Short-term Countermeasures for Nuclear or Radiological Emergencies

Purpose The purpose of this paper, builds on previous studies that explored the research patterns over 15 years, is to consider the current status of the integration of Lean and Six Sigma. More specifically, this research addresses whether Lean and Six Sigma are stronger together and explores the reasons why Lean researchers and practitioners may be less likely to integrate Six Sigma in their work. Design/methodology/approach The research utilises a survey of 25 established and respected academics and practitioners from 16 countries. The questionnaire is analysed using a direct content approach and coded in NVivo. Findings The findings suggest that challenges may lie in the perception and understanding of statistics as well as short-term rather than long-term focus on improvement. The findings also suggest that academics and practitioners believe that Lean Six Sigma has developed over time and will continue to develop and improve as a methodology rather than being replaced with a new methodology. Research limitations/implications The survey has a sample size of 25, albeit all respondents are established and very experienced practitioners and academics. Practical implications For organisations that are introducing or refreshing their continuous improvement initiatives, this research identifies some of the challenges and provides the opportunity to address them to maximise the opportunities for success and sustainability. Originality/value The value of this paper is that it further addresses the debate over the integration of Lean and Six Sigma for many organisations which still employ Lean alone, but beyond this it explores how they will continue to develop and whether they are a permanent edition to the quality management landscape or a transition to something else.

Download Full-text

Robotic gastrectomy for gastric cancer: Current status and short-term clinical outcome in our hospital

Tenri Medical Bulletin ◽

10.12936/tenrikiyo.21-014 ◽

2018 ◽

Vol 21 (2) ◽

pp. 105

Author(s):

Yoshio Kadokawa

Keyword(s):

Gastric Cancer ◽

Clinical Outcome ◽

Current Status ◽

Robotic Gastrectomy ◽

Short Term

Download Full-text

A Historical Overview Upon the Use of Amphetamine Derivatives in the Treatment of Obesity

Journal of Pharmaceutical Care ◽

10.18502/jpc.v7i3.2355 ◽

2020 ◽

Author(s):

Ștefana Stăcescu ◽

Gabriel Hancu ◽

Denisa Podar ◽

Ștefania Todea ◽

Amelia Tero-Vescan

Keyword(s):

High Efficiency ◽

Lifestyle Modification ◽

Term Treatment ◽

Current Status ◽

Historical Overview ◽

Short Term ◽

Short Term Treatment ◽

Treatment Of Obesity ◽

Amphetamine Derivatives ◽

The One

Relatively few medications are available for the management of obesity and all are indicated as adjuncts to increased physical activity, caloric restriction and lifestyle modification. Among different weight-loss drugs, the most intriguing and controversial class is the one of anorexic amphetamines, due to their high efficiency but also relevant side-effects. Several previously approved anorexic amphetamines like fenfluramine, phenylpropanolamine, phenmetrazine and sibutramine have been withdrawn from the market due to unanticipated adverse effects. Nowadays only four amphetamine derivatives are approved for short-term treatment of obesity: amfepramone, benzphetamine, phendimetrazine and phentermine. The article provides an overview of both the history, and the current status, of the use of amphetamine derivatives in the obesity pharmacotherapy. J Pharm Care 2019; 7(3): 75-82.

Download Full-text

Convalescent Plasma Therapy for COVID-19: Current Status and Future Directions

Journal of Neuroanaesthesiology and Critical Care ◽

10.1055/s-0040-1716594 ◽

2020 ◽

Vol 7 (03) ◽

pp. 140-147

Author(s):

Jayanth Seshan ◽

Surya K. Dube ◽

Vanitha Rajagopalan ◽

Pragyan S. Panda ◽

Girija P. Rath

Keyword(s):

Rescue Therapy ◽

Therapeutic Option ◽

Current Status ◽

Past Century ◽

Short Term ◽

Plasma Therapy ◽

Future Directions ◽

Health Crisis ◽

Influenza Outbreak ◽

Initial Results

AbstractThe ongoing pandemic of coronavirus disease 2019 (COVID-19) has triggered a global health crisis probably due to a lack of a reliable cure till date. Several clinical trials are ongoing, but initial results have not been overly promising. Convalescent plasma (CP), which refers to plasma collected from individuals recovered from an illness and developed antibodies against the pathogen, is also being proposed as a therapeutic option for COVID-19 treatment in severe cases to achieve short-term immunity against the virus. Use of CP is not new, and it has been used in various outbreaks over the past century, ranging from the Spanish influenza outbreak in 1918 to the recent Middle East respiratory syndrome (MERS). However, data available on its use in COVID-19 patients is limited. Use of CP so far is restricted to a “rescue therapy” and needs further trials to assess its possible use in other situations (prevention, postexposure prophylaxis) and patient populations (considering age and comorbid illnesses). In this review, we will try to summarize the current status of use of CP for COVID-19 and ongoing trials in India and elsewhere and will discuss the possible avenues for its use in future.

Download Full-text

Minimally Invasive Surgery of Rectal Cancer: Current Evidence and Options

American Society of Clinical Oncology Educational Book ◽

10.14694/edbook_am.2012.32.41 ◽

2012 ◽

pp. 214-218 ◽

Cited By ~ 2

Author(s):

Atthaphorn Trakarnsanga ◽

Martin R. Weiser

Keyword(s):

Rectal Cancer ◽

Colon Cancer ◽

Minimally Invasive Surgery ◽

Minimally Invasive ◽

Invasive Surgery ◽

Oncologic Outcomes ◽

Current Status ◽

Current Evidence ◽

Short Term ◽

Invasive Approach

Overview: Minimally invasive surgery (MIS) of colorectal cancer has become more popular in the past two decades. Laparoscopic colectomy has been accepted as an alternative standard approach in colon cancer, with comparable oncologic outcomes and several better short-term outcomes compared to open surgery. Unlike the treatment for colon cancer, however, the minimally invasive approach in rectal cancer has not been established. In this article, we summarize the current status of MIS for rectal cancer and explore the various technical options.

Download Full-text

Gender mainstreaming in Pakistani libraries: Analysing the possibilities

Journal of Librarianship and Information Science ◽

10.1177/0961000616631817 ◽

2016 ◽

Vol 49 (1) ◽

pp. 107-114 ◽

Cited By ~ 2

Author(s):

Arif Khan ◽

Rabia Anbareen ◽

Haroon Idrees ◽

Gohar Saeed

Keyword(s):

Information Science ◽

Library Science ◽

Gender Mainstreaming ◽

Current Status ◽

Library And Information Science ◽

Test Results ◽

Training Workshop ◽

Short Term ◽

Online Questionnaire ◽

Gender Perspectives

The purpose of this study is to explore the intention and competency of Library and Information Science (LIS) professionals regarding sensitivity of gender-related issues in libraries and to examine the effect of a short-term (five days) thematic training workshop on Information Management with Gender Perspectives for LIS professionals. Data was collected from working librarians around the country using two separate channels, i.e. an online questionnaire, and pre/post-training test results from the trainees of a workshop on gender mainstreaming in libraries. The findings discuss the level of competencies, need for training, and attitudinal responsiveness of LIS professionals in Pakistan and appropriate measures are discussed. Moreover, gender-related issues and the current status of LIS professionals are alarming in terms of gender responsiveness. Findings show that only 17% of the LIS community is gender responsive. The results are useful for planners of engendered programmes and policies, library science professionals and researchers, especially in the field of gender and women’s studies and provide an insight for international readers into the perception of LIS professionals on mainstreaming gender in Pakistani libraries. This study uniquely presents the current status and preparedness of LIS professionals to address gender-related issues in libraries

Download Full-text

Biosystematics of entomopathogenic nematodes: current status, protocols and definitions

Journal of Helminthology ◽

10.1017/s0022149x00016096 ◽

1997 ◽

Vol 71 (4) ◽

pp. 271-298 ◽

Cited By ~ 85

Author(s):

W.M. Hominick ◽

B.R. Briscoe ◽

F.G. del Pino ◽

Jian Heng ◽

D.J. Hunt ◽

...

Keyword(s):

Czech Republic ◽

Chemical Control ◽

Entomopathogenic Nematodes ◽

Current Status ◽

Parasitic Nematodes ◽

Short Term ◽

Management Committee ◽

Cold Active ◽

The Uk ◽

The Eu

COST Action 819: Entomopathogenic nematodes, supercedes Action 812: Cold active lines of insect parasitic nematodes in Agriculture and Biotechnology. It functions in the field of Agriculture and Biotechnology and began in July 1994 and will end in May, 1999. The main objective is to combine interrelated European expertise to increase the use of entomopathogenic nematodes (EPNs) in integrated pest management and to reduce the need for chemical control. Coordination of the Action is the responsibility of a management committee in accordance with a Memorandum of Understanding, which has been signed by representatives of 17 countries: Austria, Belgium, Czech Republic, Finland, France, Germany, Hungary, Ireland, Italy, The Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland and the UK. A research institute in Israel is also participating. Over 40 research institutions and 10 commercial companies participate in Action 819. The EU funding meets the costs related to coordination including the scientific secretariat, workshops, management committee and working group meetings, publications, short term scientific missions and evaluations.

Download Full-text

CURRENT STATUS OF SHORT-TERM SOLAR PROTON PREDICTIONS

COSPAR: Space Research ◽

10.1016/b978-0-08-023417-5.50073-9 ◽

1979 ◽

pp. 395-398

Author(s):

D.F. Smart ◽

M.A. Shea

Keyword(s):

Solar Proton ◽

Current Status ◽

Short Term

Download Full-text

Global Action against Dementia Call for Innovations

Translational Neuroscience and Clinics ◽

10.18679/cn11-6030_r.2016.037 ◽

2016 ◽

Vol 2 (4) ◽

pp. 260-274

Author(s):

Dajue Wang

Keyword(s):

Entorhinal Cortex ◽

Hippocampal Formation ◽

Long Term Potentiation ◽

Animal Assisted Therapy ◽

Current Status ◽

Short Term ◽

Term Memory ◽

Term Potentiation ◽

Pharmaceutical Industries

With the fast-growing aging population, dementia has become a health priority. However, in the past, medicine was largely dealing with physical disorders, and not enough knowledge and experience have been accumulated for mental health. The main and first symptom of this disorder is the loss of memory; hence, understanding the hippocampal formation is the key to tackling dementia. In 2007, a milestone book titled “Hippocampus Book” was published. One of the authors/editors is the 2014 Nobel Laureate in Physiology and Medicine, Professor John O'Keefe. It is a MUST-READ encyclopedia about the hippocampal formation, for those who wish to commit themselves to helping the patients with dementia. The formation consists of the hippocampus, entorhinal cortex, subiculum, presubiculum, parasubiculum, and dentate gyrus. The hippocampus is further divided into CA1, CA2, and CA3. The entorhinal cortex is the gateway of receiving all sensory information from the neocortex, while the subiculum is the exit for the efferent projections to the neocortex. Memory is divided into short-term and long-term memory. The former does not require protein synthesis while the latter does. The electrophysiological activities of creating these memories are short-term potentiation and long-term potentiation respectively. In most cases, the entorhinal cortex is the first structure to be damaged, and even short-term memory cannot be created. However, all except spatial memory are stored in the neocortex. Damage to the hippocampal formation would not affect the storage and retrieval of memories. Hence, past memories may remain intact in the early phases of the disorder. This devastating progressive disease has no cure. However, the highly plastic hippocampal formation may offer us some hope. It is the responsibility of the pharmaceutical industries to develop new drugs. Clinicians should add their efforts to the endeavor. The author would suggest that they explore insulin-like growth factors, brain stimulation, cell transplantation, and animal-assisted therapy to find some innovative solutions to help patients with dementia. As the current status of neuroscience stands, the animal-assisted therapy seems to stand out among all methods. It alleviates symptoms and stabilizes the ailment.

Download Full-text